Jemlani, Sauda M.
HRN: 29-21-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFUROXIME 1.5GM (VIAL)
06/22/2026
06/24/2026
IVTT
1.5g
Q8h
UTI
Checking Initial Appropriateness
06/26/2026
CEFAZOLIN 1GM (VIAL)
06/26/2026
06/27/2026
IV
1g
PTOR
Preop Prophylaxis
Checking Initial Appropriateness
06/27/2026
CEFUROXIME 500MG (TAB)
06/27/2026
07/04/2026
PO
500mg
BID
S/P Diagnostic Curettage
Checking Initial Appropriateness